Impact Factor
3.78
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.16
912 total citations
h5-index
32
h5 depth signal
Cited share
89.2%
199 of 223
Total citations
912
Citation footprint
Metric signal
3.47
External metric anchor
Self-citation
2.5%
23 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
426
China
304
Iran
99
United States
66
Saudi Arabia
59
Citing Fields of Research
Drug Delivery Systems
933
Polymer & Macromolecule Science
210
Nanoparticles
182
Phytochemicals
86
Nanofibers, Scaffolds & Fabrication
51
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,071
Articles tracked across the journal lifetime
Indexed publication set
223
199 cited publications
Last 12 months
153
12.8 publications/month
Open access share
5.2%
8 OA publications in the last year
Leading citing country
India
426 citing publications
Leading citing field
Drug Delivery Systems
933 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2004-
v1n1, Jan. 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Broad Categories
Drug Therapy
Pharmacology
Drug Delivery Systems
Polymer & Macromolecule Science
Nanoparticles
MeSH Descriptors
Drug Carriers
Drug Delivery Systems
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/0115672018452820261006095941
Open DOI
Pharmacological and Therapeutic Roles of Wild Pistachio and Its Nanoformulations in Endocrine, Metabolic, and Other Diseases: A Comprehensive Review
Introduction: Wild pistachio (Pistacia atlantica, P. atlantica) is a promising natural source of bioactive compounds, particularly polyphenols, that may help manage metabolic and endocrine disorders through its antioxidant, anti-inflamma...
02
DOI 10.2174/0115672018500887260930105834
Open DOI
Optimization, In vitro and In vivo Evaluation of an Azithromycin Nanosuspension-Based Nanogel for Enhanced Dermal Delivery
Introduction/Objective: Azithromycin is a BCS class II macrolide antibiotic characterized by poor aqueous solubility, a limited dissolution rate, and relatively low oral bioavailability (37%), limiting its therapeutic effectiveness for t...
03
DOI 10.2174/0115672018493958261005052727
Open DOI
Nanocarrier Systems for Nystatin Delivery: Formulation Performance and Therapeutic Implications in Candidiasis Treatment
Nystatin is a commonly used antifungal medicine for the treatment of candidiasis, particularly in superficial and mucosal infections. Its clinical usefulness is limited by poor water solubility, instability, a short residence time in the...
04
DOI 10.2174/0115672018492081260929071418
Open DOI
Engineering Nanogels for Controlled Drug Release: A Review of Synthesis and Biomedical Integration
Introduction: Nanogels are broadly tuneable nanoparticles formulated for controlled drug delivery and represent an effective means of delivering active pharmaceutical compounds. This review aims to provide a broad understanding of nanoge...
05
DOI 10.2174/0115672018403495251210132701
Open DOI
Nanobots in Precision Medicine: Transforming Drug Delivery Systems
Nanotechnology has emerged as a transformative force in modern healthcare, particularly through the innovative use of nanobots for drug delivery. These microscopic, programmable devices are designed to navigate biological systems and del...
06
DOI 10.2174/0115672018448913260923044628
Open DOI
Herbal Medicine in Episiotomy Wound Healing: A Systematic Review
Introduction: Episiotomy is a common obstetric intervention following vaginal delivery and is frequently associated with pain, delayed wound healing, and postpartum discomfort. Inadequate healing of episiotomy wounds may result in infect...
07
DOI 10.2174/0115672018510883260914050642
Open DOI
From Laboratory to Clinic: Translational Challenges, Lessons, and Future Strategies for microRNA Delivery Systems
MicroRNA (miRNA)-based therapeutics can modulate disease-associated gene networks by restoring protective miRNAs or inhibiting pathogenic miRNAs, yet clinical translation remains limited despite substantial preclinical progress. This rev...
08
DOI 10.2174/0115672018485352260907113702
Open DOI
Engineering Principles of Extracellular Vesicles for Central Nervous System Therapies
Extracellular Vesicles (EVs) are active mediators of intercellular signaling in the Central Nervous System (CNS), operating alongside synaptic transmission as an extra form of wireless communication between neurons and other brain cell t...
09
DOI 10.2174/0115672018496503260910072814
Open DOI
Therapeutic Potential of Protein-Based Polymers as Nanocarriers for Drug Delivery
Introduction/Objective: Protein-based polymeric nanocarriers are increasingly being investigated as biodegradable, biocompatible systems for drug and gene delivery. This review critically examines major protein-based polymeric nanocarrie...
10
DOI 10.2174/0115672018474663260907142216
Open DOI
Advances in Novel Drug Delivery Systems for Targeting the Brain: Overcoming Barriers and Enhancing Therapeutic Efficacy
The blood-brain barrier (BBB) is critical in CNS pharmacotherapy; it blocks the entry of 98 per cent of small-molecule compounds and almost all macromolecules into the brain parenchyma via tight junction complexes, efflux transporter act...
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 1, no. 2 (Apr. 2004).
Also issued online.